User:Mr. Ibrahem/Deferiprone

Deferiprone, sold under the brand name Ferriprox among others, is a medication used to treat iron overload due to blood transfusions in thalassaemia major. It is taken by mouth. Evidence supports improved blood markers but not symptoms or survival.

Common side effects include red-brown urine, nausea, abdominal pain, and vomiting. Other side effects may include low white blood cells, infection, and prolonged QT. Use in pregnancy may harm the baby. It is an iron chelator.

Deferiprone became commercially available in 1994. It was initially approved in Europe and Asia. It is on the World Health Organization's List of Essential Medicines as an alternative to deferasirox. It is available as a generic medication. This was followed by approval in the United States in 2011. In the United Kingdom 100 tablets of 500 mg costs the NHS about £130. In the United States this amount costs about 7,500 USD.